Articles about Product Safety

AI in Medical Imaging Market: North America Leads Global Revenue ↗

September 24, 2026

Definium Therapeutics Highlights Phase III DT120 Gains in Anxiety and Depression ↗

September 24, 2026

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) is November 3, 2026

September 23, 2026

Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 28, 2026 Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)

September 23, 2026

ELIS Manufacturing & Packaging Details Sports Nutrition Manufacturing Standards in GMP Certified Facility

The Holy Grail In Cancer? FDA Mulls New Blood Tests. ↗

September 23, 2026

Via Investor's Business Daily

September 23, 2026

Via Press Advantage

Kaplan Fox Reminds Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors of an Ongoing Securities Law Investigation

September 23, 2026

Kaplan Fox Announces an Investigation of Medline Inc. (NASDAQ: MDLN) on Behalf of Investors

September 23, 2026

Buy Phentermine Online: Eligibility, Clinical Review, and How Legal Access Works ↗

September 23, 2026

Lucid Approaches a Make-or-Break Period as Preparation for Turnaround Begins ↗

September 23, 2026

Via The Motley Fool

Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Success ↗

September 22, 2026

Kaplan Fox Deadline Alert: Beta Bionics, Inc. (NASDAQ: BBNX) Investors Have Until November 3, 2026 to Seek a Lead Plaintiff Role

September 22, 2026

Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026

Quetiapine For Schizophrenia Treatment: Usage & Side Effects Guide Released

September 22, 2026

Via Press Release Distribution Service

September 22, 2026

Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026

Compassion Behavioral Health Publishes New Resource on GLP-1 Research

September 22, 2026

Via Press Advantage

September 22, 2026

Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances ↗

September 22, 2026

Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026

September 22, 2026

MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Receives USPTO Notice of Allowance for LP-284 Blood Cancer Treatment Patent

September 22, 2026

Via Investor Brand Network

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026

September 22, 2026

PureTech Health H1 Earnings Call Highlights ↗

September 22, 2026

Compass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears ↗

September 22, 2026

Liquid Rhinoplasty for Subtle Nose Enhancement ↗

September 22, 2026

Morpheus8 Radiofrequency for Skin and Scar Refinement ↗

September 22, 2026

Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion ↗

September 21, 2026

Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026

September 21, 2026

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026

Non-Invasive Neuromodulation Support for Heart Rate Variability: Guide Published

September 21, 2026

Via Press Release Distribution Service

BPC-157 & TB-500 Peptide Strips for Recovery Support: Wolverine Stack Launched

September 21, 2026

Via Press Release Distribution Service

September 21, 2026